Log in
Enquire now
‌

US Patent 9555112 Monoclonal antibodies against HER2 epitope and methods of use thereof

Patent 9555112 was granted and assigned to Mersana Therapeutics on January, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Mersana Therapeutics
Mersana Therapeutics
Current Assignee
Mersana Therapeutics
Mersana Therapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9555112
Date of Patent
January 31, 2017
Patent Application Number
14742947
Date Filed
June 18, 2015
Patent Citations Received
‌
US Patent 11786605 Site specific antibody-drug conjugates with peptide-containing linkers
Patent Primary Examiner
‌
Laura B Goddard
Patent abstract

This invention provides fully human monoclonal antibodies that recognize HER2. The invention further provides methods of using such monoclonal antibodies in a variety of therapeutic, diagnostic, and prophylactic indications.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9555112 Monoclonal antibodies against HER2 epitope and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.